This data provides additional evidence in support of the hypothesis that obesity-associated systemic factors suppress breast cancer cell ERβ expression via a HER2-mediated signaling pathway. The gene discussed is ERBB2; the disease is obesity due to melanocortin 4 receptor deficiency.